Sleep apnoea and hypoventilation syndromes - cardiometabolic consequences Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy Year: 2018
Cardiovascular comorbidity in obesity hypoventilation syndrome: has nocturnal hypoventilation a protective effect? Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017
Factors influencing efficacy of BiPAP therapy in severe obstructive sleep apnea Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013
Phrenic neuropathy: an unrecognized factor worsening obesity hypoventilation and obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Analysis of circadian blood pressure rhythms and cardiovascular risk factors in patients with hypertension and sleep apnea syndrome Source: International Congress 2014 – Sleep disordered breathing 5 Year: 2014
Risk factors of hypercapnia in patient with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Efficacy of auto-trilevel positive airway ventilation on patients with both obesity hypoventilation and obstructive sleep apnea syndromes Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques Year: 2013
Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013
Sleep and breathing in neuromuscular disease Source: Eur Respir J 2002; 19: 1194-1201 Year: 2002
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
A comparison of breathing patterns in NIV patients with neuromuscular disease, hypoventilation syndrome and COPD Source: Eur Respir J 2007; 30: Suppl. 51, 205s Year: 2007
Sleep and neuromuscular disease in childhood and adolescence Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=254 Year: 2002
Autonomic arousals, sleep respiratory disorders and autonomic nervous system activity in neuromuscular diseases Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea Year: 2016
Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006
Nocturnal hypoxaemia and hypercapnia in children with neuromuscular disorders Source: Eur Respir J 2012; 39: 1206-1212 Year: 2012
Ventilatory management in COPD-associated obstructive sleep apnea syndrome Source: International Congress 2015 – Novelties in noninvasive ventilation Year: 2015
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015